MicroRNAs as oncogenes or tumour suppressors in oesophageal cancer: Potential biomarkers and therapeutic targets

Cell Proliferation

Volumn 47, Issue 4, 2014, Pages 277-286

  Huang, J ^a   Zhang, S Y ^b   Gao, Y M ^c   Liu, Y F ^c   Liu, Y B ^d   Zhao, Z G ^e   Yang, K ^f  

^a SHENYANG PHARMACEUTICAL UNIVERSITY   (China)

^b SICHUAN UNIVERSITY   (China)

^c The first attached hospital of hebei northern institute   (China)

^d GENERAL HOSPITAL OF CHINESE PEOPLE'S ARMED POLICE FORCES   (China)

^e Gastrointestinal and Hepatobiliary Surgery Department of Baotou Tumour Hospital   (China)

^f Department of Pediatrics Medical Center of Dujiangyan   (China)

Author keywords

[No Author keywords available]

Indexed keywords

FASCIN; MATRIX METALLOPROTEINASE 14; MICRORNA; MICRORNA 100; MICRORNA 101; MICRORNA 125B; MICRORNA 192; MICRORNA 200C; MICRORNA 21; MICRORNA 214; MICRORNA 223; MICRORNA 31; MICRORNA 34A; TRANSCRIPTION FACTOR EZH2; TUMOR PROMOTER;

APOPTOSIS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER THERAPY; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; GENETIC VARIABILITY; HUMAN; METASTASIS; ONCOGENE; REVIEW; TUMOR SUPPRESSOR GENE; UPREGULATION;

ANIMALS; ESOPHAGEAL NEOPLASMS; ESOPHAGUS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HUMANS; MICRORNAS; ONCOGENES; TUMOR MARKERS, BIOLOGICAL;

EID: 84903756762     PISSN: 09607722     EISSN: 13652184     Source Type: Journal    
DOI: 10.1111/cpr.12109     Document Type: Review

References (70)

1. Tran N, Hutvagner G (2013) Biogenesis and the regulation of the maturation of miRNAs. Essays Biochem. 4, 17-28.
2. Lee RC, Feinbaum RL, Ambros V (1993) The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 75, 843-854.
3. Saj A, Lai EC (2011) Control of microRNA biogenesis and transcription by cell signaling pathways. Curr. Opin. Genet. Dev. 21, 504-510.
4. Borchert GM, Lanier W, Davidson BL (2006) RNA polymerase III transcribes human microRNAs. Nat. Struct. Mol. Biol. 13, 1097-1101.
5. Iorio MV, Croce CM (2012) MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol. Med. 4, 143-159.
6. Bartel DP (2009) MicroRNAs: target recognition and regulatory functions. Cell 136, 215-233.
7. Fabian MR, Sonenberg N (2012) The mechanics of miRNA-mediated gene silencing: a look under the hood of miRISC. Nat. Struct. Mol. Biol. 19, 586-593.
8. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E et al. (2002) Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc. Natl. Acad. Sci. USA 99, 15524-15529.
9. Nelson PT, Baldwin DA, Scearce LM, Oberholtzer JC, Tobias JW, Mourelatos Z (2004) Microarray-based, high-throughput gene expression profiling of microRNAs. Nat. Methods 1, 155-161.
10. Gu J, Wang Y, Wu X (2013) MicroRNA in the pathogenesis and prognosis of esophageal cancer. Curr. Pharm. Des. 19, 1292-1300.
11. Hongo M, Nagasaki Y, Shoji T (2009) Epidemiology of esophageal cancer: Orient to Occident. Effects of chronology, geography and ethnicity. J. Gastroenterol. Hepatol. 24, 729-735.
12. Trivers KF, Sabatino SA, Stewart SL (2008) Trends in esophageal cancer incidence by histology, United States, 1998-2003. Int. J. Cancer 123, 1422-1428.
13. Brown LM, Devesa SS, Chow WH (2008) Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J. Natl. Cancer Inst. 100, 1184-1187.
14. Whiteman DC, Sadeghi S, Pandeya N, Smithers BM, Gotley DC, Bain CJ et al.; Australian Cancer Study (2008) Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the esophagus. Gut 57, 173-180.
15. Anderson LA, Watson RG, Murphy SJ, Johnston BT, Comber H, Mc Guigan J et al. (2007) Risk factors for Barrett's oesophagusesophagus and oesophageal adenocarcinoma: results from the FINBAR study. World J. Gastroenterol. 13, 1585-1594.
16. Toh Y, Egashira A, Yamamoto M (2013) Epigenetic alterations and their clinical implications in esophageal squamous cell carcinoma. Gen. Thorac. Cardiovasc. Surg. 61, 262-269.
17. David S, Meltzer SJ (2011) MicroRNA involvement in esophageal carcinogenesis. Curr. Opin. Pharmacol. 11, 612-616.
18. Lv J, Cao XF, Zhu B, Ji L, Tao L, Wang DD (2009) Effect of neoadjuvant chemoradiotherapy on prognosis and surgery for esophageal carcinoma. World J. Gastroenterol. 15, 4962-4968.
19. Wang N, Zhang CQ, He JH, Duan XF, Wang YY, Ji X et al. (2013) MiR-21 down-regulation suppresses cell growth, invasion and induces cell apoptosis by targeting FASL, TIMP3, and RECK genes in esophageal carcinoma. Dig. Dis. Sci. 58, 1863-1870.
20. Weng W, Wu Q, Yu Y, Mei W, Wang X (2013) A novel chemotherapeutic arene ruthenium(II) drug Rawq01 altered the effect of microRNA-21 on PTEN/AKT signaling pathway in esophageal cancer cells. Anticancer Res. 33, 5407-5414.
21. Alder H, Taccioli C, Chen H, Jiang Y, Smalley KJ, Fadda P et al. (2012) Dysregulation of miR-31 and miR-21 induced by zinc deficiency promotes esophageal cancer. Carcinogenesis 33, 1736-1744.
22. Chen ZL, Zhao XH, Wang JW, Li BZ, Wang Z, Sun J et al. (2011) microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 286, 10725-10734.
23. Wang K, Li J, Guo H, Xu X, Xiong G, Guan X et al. (2012) MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis 33, 2147-2154.
24. Yu H, Duan B, Jiang L, Lin M, Sheng H, Huang J et al. (2013) Serum miR-200c and clinical outcome of patients with advanced esophageal squamous cancer receiving platinum-based chemotherapy. Am. J. Transl. Res. 6, 71-77.
25. Matsuzaki J, Suzuki H, Tsugawa H, Watanabe M, Hossain S, Arai E et al. (2013) Bile acids increase levels of microRNAs 221 and 222, leading to degradation of CDX2 during esophageal carcinogenesis. Gastroenterology 145, 1300-1311.
26. Streppel MM, Pai S, Campbell NR, Hu C, Yabuuchi S, Canto MI et al. (2013) MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin. Cancer Res. 19, 4067-4078.
27. Lee KH, Goan YG, Hsiao M, Lee CH, Jian SH, Lin JT et al. (2009) MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp. Cell Res. 315, 2529-2538.
28. Yuan X, He J, Sun F, Gu J (2013) Effects and interactions of MiR-577 and TSGA10 in regulating esophageal squamous cell carcinoma. Int. J. Clin. Exp. Pathol. 6, 2651-2667.
29. Liu Q, Lv GD, Qin X, Gen YH, Zheng ST, Liu T et al. (2012) Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol. Biol. Rep. 39, 1239-1246.
30. Sugimura K, Miyata H, Tanaka K, Hamano R, Takahashi T, Kurokawa Y et al. (2012) Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin. Cancer Res. 18, 5144-5153.
31. Li J, Wang K, Chen X, Meng H, Song M, Wang Y et al. (2012) Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol. Biol. 13, 4.
32. Huang SD, Yuan Y, Zhuang CW, Li BL, Gong DJ, Wang SG et al. (2012) MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol. Cancer 11, 51.
33. Sun J, Chen Z, Tan X, Zhou F, Tan F, Gao Y et al. (2013) MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med. Oncol. 30, 411.
34. Kang M, Li Y, Liu W, Wang R, Tang A, Hao H et al. (2013) miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression. Int. J. Mol. Med. 32, 51-58.
35. Suzuki S, Yokobori T, Tanaka N, Sakai M, Sano A, Inose T et al. (2012) CD47 expression regulated by the miR-133a tumor suppressor is a novel prognostic marker in esophageal squamous cell carcinoma. Oncol. Rep. 28, 465-472.
36. Akanuma N, Hoshino I, Akutsu Y, Murakami K, Isozaki Y, Maruyama T et al. (2014) MicroRNA-133a regulates the mRNAs of two invadopodia-related proteins, FSCN1 and MMP14, in esophageal cancer. Br. J. Cancer 110, 189-198.
37. Gong H, Song L, Lin C, Liu A, Lin X, Wu J et al. (2013) Downregulation of miR-138 sustains NF-κB activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin. Cancer Res. 19, 1083-1093.
38. Ni Y, Meng L, Wang L, Dong W, Shen H, Wang G et al. (2013) MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 517, 197-204.
39. Yokobori T, Suzuki S, Tanaka N, Inose T, Sohda M, Sano A et al. (2013) MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 104, 48-54.
40. Zhang HF, Zhang K, Liao LD, Li LY, Du ZP, Wu BL et al. (2014) miR-200b suppresses invasiveness and modulates the cytoskeletal and adhesive machinery in esophageal squamous cell carcinoma cells via targeting Kindlin-2. Carcinogenesis 35, 292-301.
41. Yu X, Li H, Jiang X, Guo L, Jiang W, Lu SH (2014) MiR-203 inhibits the proliferation and self-renewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Stem Cells Dev. 23, 576-585.
42. Takeshita N, Mori M, Kano M, Hoshino I, Akutsu Y, Hanari N et al. (2013) miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1. Int. J. Oncol. 41, 1653-1661.
43. Isozaki Y, Hoshino I, Nohata N, Kinoshita T, Akutsu Y, Hanari N et al. (2012) Identification of novel molecular targets regulated by tumor suppressive miR-375 induced by histone acetylation in esophageal squamous cell carcinoma. Int. J. Oncol. 41, 985-994.
44. Wang Y, Li M, Zang W, Ma Y, Wang N, Li P et al. (2013) MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol. (Dordr) 36, 385-394.
45. Zhang M, Zhou S, Zhang L, Zhang J, Cai H, Zhu J et al. (2012) miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Lett. 586, 3508-3521.
46. Wang Y, Zang W, Du Y, Ma Y, Li M, Li P et al. (2013) Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma. J. Transl. Med. 11, 301.
47. Wu X, Ajani JA, Gu J, Chang DW, Tan W, Hildebrandt MA et al. (2013) MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma. Cancer Prev. Res. (Phila) 6, 196-205.
48. van Soest EM, Dieleman JP, Siersema PD, Sturkenboom MC, Kuipers EJ (2005) Increasing incidence of Barrett's oesophagus in the general population. Gut 54, 1062-1066.
49. Fassan M, Volinia S, Palatini J, Pizzi M, Baffa R, De Bernard M et al. (2011) MicroRNA expression profiling in human Barrett's carcinogenesis. Int. J. Cancer 129, 1661-1670.
50. Bansal A, Lee IH, Hong X, Anand V, Mathur SC, Gaddam S et al. (2011) Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am. J. Gastroenterol. 106, 1055-1063.
51. Maru DM, Singh RR, Hannah C, Albarracin CT, Li YX, Abraham R et al. (2009) miRNA- 196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol. 174, 1940-1948.
52. Hu Y, Correa AM, Hoque A, Guan B, Ye F, Huang J et al. (2011) Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 128, 132-143.
53. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y et al. (2007) A microRNA component of the p53 tumor suppressor network. Nature 447, 1130-1134.
54. Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Morimura R, Nagata H et al. (2011) Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 105, 104-111.
55. Hummel R, Hussey DJ, Michael MZ, Haier J, Bruewer M, Senninger N et al. (2011) MiRNAs and their association with locoregional staging and survival following surgery for esophageal carcinoma. Ann. Surg. Oncol. 18, 253-260.
56. Shah AK, Saunders NA, Barbour AP, Hill MM (2013) Early diagnostic biomarkers for esophageal adenocarcinoma-the current state of play. Cancer Epidemiol. Biomarkers Prev. 22, 1185-1209.
57. Song JH, Meltzer SJ (2012) MicroRNAs in pathogenesis, diagnosis, and treatment of gastroesophageal cancers. Gastroenterology 143, 35-47.
58. Hong L, Han Y, Zhang H, Li M, Gong T, Sun L et al. (2010) The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann. Surg. 251, 1056-1063.
59. Zhang H, Li M, Han Y, Hong L, Gong T, Sun L et al. (2010) Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig. Dis. Sci. 55, 2545-2551.
60. Guo Y, Chen Z, Zhang L, Zhou F, Shi S, Feng X et al. (2008) Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 68, 26-33.
61. Ogawa R, Ishiguro H, Kuwabara Y, Kimura M, Mitsui A, Katada T et al. (2009) Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med. Mol. Morphol. 42, 102-109.
62. Tanaka K, Miyata H, Yamasaki M, Sugimura K, Takahashi T, Kurokawa Y et al. (2013) Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann. Surg. Oncol. 20, S607-S615.
63. Sharma P, Saraya A, Gupta P, Sharma R (2013) Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarksers 18, 322-330.
64. Hirajima S, Komatsu S, Ichikawa D, Takeshita H, Konishi H, Shiozaki A et al. (2013) Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 108, 1822-1829.
65. Liu R, Liao J, Yang M, Shi Y, Peng Y, Wang Y (2012) Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J. Toxicol. Environ. Health A 75, 1154-1162.
66. Odenthal M, Bollschweiler E, Grimminger PP, Schröder W, Brabender J, Drebber U et al. (2013) MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int. J. Cancer 133, 2454-2463.
67. Hummel R1, Watson DI, Smith C, Kist J, Michael MZ, Haier J (2011) Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J. Gastrointest. Surg. 15, 429-438.
68. Lennox KA, Behlke MA (2011) Chemical modification and design of anti-miRNA oligonucleotides. Gene Ther. 18, 1111-1120.
69. Nana-Sinkam SP, Croce CM (2013) Clinical applications for microRNAs in cancer. Clin. Pharmacol. Ther. 93, 98-104.
70. Cho WC (2012) MicroRNAs as therapeutic targets and their potential applications in cancer therapy. Expert Opin. Ther. Targets 16, 747-759.